Discontinued — last reported Q4 '25
Treasury Stock
EquityEli Lilly Treasury Stock increased by 12.8% to $62.50M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 91.1%, from $32.70M to $62.50M. Over 4 years (FY 2020 to FY 2024), Treasury Stock shows a downward trend with a -2.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ4 2008
Last reportedQ4 2025
How to read this metric
An increase signals that the company is returning capital to shareholders, often viewed as a sign of management's confidence in the stock's value.
Detailed definition
The cost of shares that the company has repurchased from the open market and is holding in its own treasury. These share...
Peer comparison
Aggressive buyback programs are common at Apple and Alphabet to offset share-based compensation.
Metric ID:
treasury_stockHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $52.70M | $52.70M | $52.70M | $50.50M | $50.50M | $50.50M | $50.50M | $45.00M | $45.00M | $45.00M | $44.20M | $32.70M | $32.70M | $32.70M | $49.50M | $49.50M | $55.40M | $62.50M |
| QoQ Change | — | +0.0% | +0.0% | -4.2% | +0.0% | +0.0% | +0.0% | -10.9% | +0.0% | +0.0% | -1.8% | -26.0% | +0.0% | +0.0% | +51.4% | +0.0% | +11.9% | +12.8% |
| YoY Change | — | — | — | — | -4.2% | -4.2% | -4.2% | -10.9% | -10.9% | -10.9% | -12.5% | -27.3% | -27.3% | -27.3% | +12.0% | +51.4% | +69.4% | +91.1% |
Range$32.70M – $62.50M
CAGR+4.1%
Avg YoY Growth+6.0%
Median YoY Growth-7.5%
Current Streak6 quarters growth
Treasury Stock at Other Companies
Frequently Asked Questions
- What is Eli Lilly's treasury stock?
- Eli Lilly (LLY) reported treasury stock of $62.50M in Q3 2025.
- How has Eli Lilly's treasury stock changed year-over-year?
- Eli Lilly's treasury stock increased by 91.1% year-over-year, from $32.70M to $62.50M.
- What is the long-term trend for Eli Lilly's treasury stock?
- Over 4 years (2020 to 2024), Eli Lilly's treasury stock has grown at a -2.9% compound annual growth rate (CAGR), from $55.70M to $49.50M.
- What does treasury stock mean?
- The value of shares the company bought back from investors and kept.